NIPH
BPMC

NN Investment Partners Holdings’s Blueprint Medicines BPMC Stock Holding History

NN Investment Partners Holdings’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,300
Closed -$290K – 798
2021
Q2 		$290K Buy
+3,300
New +$302K ﹤0.01% 746

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

NN Investment Partners Holdings's BPMC Position: Q3 2021 in Review

NN Investment Partners Holdings sold out of Blueprint Medicines (BPMC) in Q3 2021, closing a stake of 3,300 shares — an estimated $290K sold.

NN Investment Partners Holdings first reported a position in BPMC in Q2 2021 and held it in 1 quarter. The position peaked at $290K in Q2 2021. 288 funds tracked by Wall St. Rank hold BPMC as of Q3 2021.

  • NN Investment Partners Holdings reported no remaining Blueprint Medicines position as of Q3 2021 after selling out during the quarter.
  • NN Investment Partners Holdings sold 3,300 Blueprint Medicines shares in Q3 2021, an estimated $290K.
  • NN Investment Partners Holdings first reported a position in Blueprint Medicines in Q2 2021 and held it in 1 quarter.
  • NN Investment Partners Holdings's Blueprint Medicines position peaked at $290K in Q2 2021.
  • 288 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2021.

Based on NN Investment Partners Holdings's 13F filing for Q3 2021, filed 10 Nov 2021.